[시장보고서]의료 데이터 기술 시장 규모, 점유율, 동향 분석 : 기술별, 지역별, 부문별 예측(2025-2033년)

의료 데이터 기술 시장 규모, 점유율, 동향 분석 : 기술별, 지역별, 부문별 예측(2025-2033년)

Healthcare Data Technology Market Size, Share & Trends Analysis Report By Technology (Data Harmonization & Structuring, Health Data Integration & Monetization), By Region, And Segment Forecasts, 2025 - 2033

상품코드 : 1888638

리서치사 : Grand View Research

발행일 : 2025년 11월

페이지 정보 : 영문 190 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,950

￦ 8,620,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950

￦ 10,069,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950

￦ 12,967,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

의료 데이터 기술 시장 : 개요

세계의 의료 데이터 기술 시장 규모는 2024년에 31억 달러로 추정되며, 2033년까지 95억 달러에 달할 것으로 예측됩니다.

2025년부터 2033년까지 CAGR 13.36%로 성장할 것으로 예상됩니다. 시장 성장은 전자건강기록(EHR), 커넥티드 디바이스, 실제 증거를 통한 건강 데이터 양의 증가에 의해 주도되고 있습니다.

AI, 고급 분석 기술, 상호운용성 솔루션의 도입, 데이터 프라이버시 및 수익화에 대한 관심이 높아지면서 시장 확대가 더욱 가속화되고 있습니다. 2024년 12월 CDC 데이터에 따르면, 미국 내 의원급 의사의 88.2%가 EMR/EHR 시스템을 사용하고 있으며, 그 중 77.8%가 인증된 시스템을 사용하고 있다고 합니다. EHR의 광범위한 도입이 의료 데이터 통합 및 분석 솔루션에 대한 수요를 주도하고 있습니다.

의료 기관이 IT 전략에서 데이터 통합, 상호운용성, AI 기반 혁신을 우선시하는 경향이 강화되면서 시장은 견조한 성장세를 보이고 있습니다. 통합된 환자 데이터, 효율적인 임상 워크플로우, 성과 기반 의료에 대한 요구에 힘입어 급속한 디지털화는 IT 예산의 근본적인 재분배를 가져오고 있습니다. 조직은 기존 인프라에서 통합을 중시하는 클라우드 지원 및 AI 지원형 시스템으로 전환하고 있으며, 데이터 기술을 업무 및 임상 혁신의 핵심으로 삼고 있습니다. 이러한 발전은 효과적인 데이터 통합이 디지털 성숙도 달성, 환자 결과 개선, 차세대 의료 서비스 모델 도입 촉진에 필수적이라는 인식이 확산되고 있음을 보여줍니다.

또한, 의료 데이터의 조화, 표준화 및 통합을 위한 국제 및 국가적 이니셔티브를 통해 시장은 괄목할 만한 성장을 이루고 있습니다. 조직과 정부는 환자 치료 개선, 연구 지원, 가치 기반 의료 모델 실현을 위해 임상, 사회, 업무 데이터세트를 통합하는 전략에 대한 투자를 확대하고 있습니다. 기술 공급업체, 공중보건기관, 국제기구 간의 협력은 상호운용성 표준 채택, 건강의 사회적 결정요인(SDOH) 통합, 고급 데이터 공유 프레임워크의 추진을 주도하고 있습니다. 이러한 노력은 의료 데이터의 가용성과 실용성을 확대하고, 분석, AI, 예측 모델링이 발전할 수 있는 견고한 생태계를 구축하고 있습니다. 의료 혁신과 업무 효율화의 중요한 원동력으로 데이터의 조화와 구조화를 꼽을 수 있습니다.

시장 점유율 변동 분석 : 기술별(2024년·2033년)
시장 규모 예측과 동향 분석 : 기술별(2021-2033년)
의료 데이터의 통합·수익화
- 데이터 통합 플랫폼
- 데이터 수익화/분석 기능 실현
- 데이터 제휴와 기록 조합
데이터 조화·구조화
- 전처리/분석 준비
- 데이터 표준화 툴
- 서드파티에 의한 데이터 강화
프라이버시 보호·익명화 기술
- 가역적인 익명화/가명화
- 비가역적 익명화
- 프라이버시 컴플라이언스 및 거버넌스 툴

제5장 의료 데이터 기술 시장 : 지역별 추정·동향 분석

시장 대시보드 : 지역별
시장의 주요 포인트 : 지역별
북미
- 미국
- 캐나다
- 멕시코
유럽
- 독일
- 영국
- 프랑스
- 이탈리아
- 스페인
- 덴마크
- 스웨덴
- 노르웨이
아시아태평양
- 일본
- 중국
- 인도
- 한국
- 호주
- 태국
라틴아메리카
- 브라질
- 아르헨티나
중동 및 아프리카
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트
- 쿠웨이트

제6장 경쟁 구도

진출 기업 외용
기업의 시장 포지션 분석/점유율 분석(2024년)
기업 분류
전략 매핑
기업 개요/상장 정보
- IQVIA
- Veeva Systems
- Medidata(Dassault Systemes)
- BC Platforms
- Quantexa
- Lifebit Biotech Inc.
- FITFILE
- Umedor Ltd
- Aridhia Digital Research Environment
- OM1
- Syneos Health
- Thermo Fisher Scientific Inc.
- Health Data Technologies GmbH
- TriNetX, LLC
- Flatiron Health
- Arcturis Data Limited
- CRIStal Health Limited t/a Akrivia Health
- Holmusk
- Huma
- ICON, plc
- Privitar(Informatica Inc.)
- Datavant
- CogStack
- Evidentli
- The Hyve
- DataRobot, Inc.
- CLARIFY
- Komodo Health, Inc.
- Evidation Health, Inc.
- Oracle(Cerner Corporation)
- Optum, Inc.(UnitedHealth Group)
- Veradigm LLC(formerly Allscripts Healthcare Solutions, Inc)
- DECENTRIQ
- Shaip
- Satori Cyber Ltd
- LynxCare

KSM

영문 목차

영문목차

Healthcare Data Technology Market Summary

The global healthcare data technology market size was estimated at USD 3.10 billion in 2024 and is projected to reach USD 9.5 billion by 2033, growing at a CAGR of 13.36% from 2025 to 2033. Market growth is driven by the increasing volume of health data from EHRs, connected devices, and real-world evidence.

The adoption of AI, advanced analytics, interoperability solutions, and a growing focus on data privacy and monetization further accelerates market expansion. In December 2024, according to CDC data, 88.2% of U.S. office-based physicians used an EMR/EHR system, with 77.8% using a certified system. Widespread EHR adoption is driving demand for healthcare data integration and analytics solutions.

The market is experiencing strong growth as healthcare organizations increasingly prioritize data integration, interoperability, and AI-driven transformation in their IT strategies. The sector's rapid digitalization, driven by the need for unified patient data, efficient clinical workflows, and outcome-based care, leads to a fundamental reallocation of IT budgets. Organizations are shifting from traditional infrastructure toward integration-focused, cloud-enabled, and AI-supported systems, positioning data technologies at the core of operational and clinical innovation. This evolution underscores a growing recognition that effective data integration is crucial for attaining digital maturity, enhancing patient outcomes, and facilitating the adoption of next-generation healthcare delivery models.

Moreover, the market is experiencing significant growth fueled by global and national initiatives to harmonize, standardize, and integrate healthcare data. Organizations and governments are increasingly investing in strategies that combine clinical, social, and operational datasets to enhance patient care, support research, and enable value-based healthcare models. Partnerships among technology vendors, public health agencies, and international bodies drive the adoption of interoperable standards, the integration of social determinants of health (SDOH), and advanced data-sharing frameworks. These efforts are expanding the availability and usability of health data, creating a robust ecosystem where analytics, AI, and predictive modeling thrive. This positioning of data harmonization and structuring as a critical driver for healthcare innovation and operational efficiency is key.

Global Healthcare Data Technology Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global healthcare data technology market report based on technology and region:

Technology Outlook (Revenue, USD Million, 2021 - 2033)
Health Data Integration & Monetization
- Data Integration Platforms
- Data Monetisation/Analytics Enablement
- Data Linkage & Record Matching
Data Harmonisation & Structuring
- Preprocessing/Analytic Readiness
- Data Standardisation Tools
- Third-party Data Enrichment
Privacy & De-identification Technologies
- Reversible De-ID/Pseudonymisation
- Irreversible Anonymisation
- Privacy Compliance & Governance Tools
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Thailand
Latin America
- Brazil
- Argentina
Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. Technology
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
- 1.5.1. Purchased Database
- 1.5.2. GVR's Internal Database
- 1.5.3. Secondary Sources
- 1.5.4. Primary Research
1.6. Information Analysis
- 1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
- 1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
  - 3.2.1.1. Budget Allocation & Investment Trends in Healthcare Data Technology
  - 3.2.1.2. Strategic Global and National Efforts in Healthcare Data Harmonization
  - 3.2.1.3. Driving Healthcare Insights Through Data Harmonization & Structuring
  - 3.2.1.4. Rising Need for Centralized and Streamlined Healthcare Administration Driving Data Integration Adoption
- 3.2.2. Market Restraint Analysis
  - 3.2.2.1. Threats To Data Security
  - 3.2.2.2. Lack of Adequate Healthcare IT Infrastructure and eHealth Readiness in Developing Regions
- 3.2.3. Industry Opportunity Analysis
  - 3.2.3.1. Driving ROI in Value-Based Care: Opportunities in Population Health Data Integration
  - 3.2.3.2. Real-World Evidence (RWE) & clinical-trial acceleration
  - 3.2.3.3. Monetizing Healthcare Data Through HL7 FHIR Integration & SMART-on-FHIR Applications
- 3.2.4. Industry Challenge Analysis
  - 3.2.4.1. Challenges in Healthcare Data Integration
  - 3.2.4.2. Diversity of data sources
  - 3.2.4.3. Data privacy and security
  - 3.2.4.4. Technological barriers
  - 3.2.4.5. Challenges in Healthcare Data Harmonization
  - 3.2.4.6. Inconsistent Data Formats
  - 3.2.4.7. Variations in Schema and Terminology
  - 3.2.4.8. Data Quality Challenges
  - 3.2.4.9. Integration Complexity
- 3.2.5. Case Studies
  - 3.2.5.1. Health Data Integration & Monetization
  - 3.2.5.2. Privacy & De-identification Technologies
  - 3.2.5.3. Data Harmonization & Structuring
- 3.2.6. Technology Overview: Existing and Emerging, by Segments
  - 3.2.6.1. Data Harmonization & Structuring
  - 3.2.6.2. Existing Technology
  - 3.2.6.3. Emerging Technology
  - 3.2.6.4. Health Data Integration & Monetization
  - 3.2.6.5. Existing Technology
  - 3.2.6.6. Emerging Technology
  - 3.2.6.7. Privacy & De-identification Technologies
  - 3.2.6.8. Existing Technology
  - 3.2.6.9. Emerging Technology
- 3.2.7. Business Environment Analysis
  - 3.2.7.1. Porter's Five Forces Analysis
    - 3.2.7.1.1. Supplier power
    - 3.2.7.1.2. Buyer power
    - 3.2.7.1.3. Substitution threat
    - 3.2.7.1.4. Threat of new entrant
    - 3.2.7.1.5. Competitive rivalry
  - 3.2.7.2. PESTLE Analysis
    - 3.2.7.2.1. Political landscape
    - 3.2.7.2.2. Economic and Social landscape
    - 3.2.7.2.3. Technological landscape
    - 3.2.7.2.4. Environmental landscape
    - 3.2.7.2.5. Legal Landscape

Chapter 4. Healthcare Data Technology Market: Technology Estimates & Trend Analysis

4.1. Technology Segment Dashboard
4.2. Technology Market Share Movement Analysis, 2024 & 2033
4.3. Market Size & Forecasts and Trend Analysis, by Technology, 2021 to 2033 (USD Million)
4.4. Health Data Integration & Monetization
- 4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4.2. Data Integration Platforms
  - 4.4.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4.3. Data Monetisation/Analytics Enablement
  - 4.4.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4.4. Data Linkage & Record Matching
  - 4.4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Data Harmonisation & Structuring
- 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5.2. Preprocessing/Analytic Readiness
  - 4.5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5.3. Data Standardisation Tools
  - 4.5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5.4. Third-party Data Enrichment
  - 4.5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Privacy & De-identification Technologies
- 4.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.6.2. Reversible De-ID/Pseudonymisation
  - 4.6.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.6.3. Irreversible Anonymisation
  - 4.6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.6.4. Privacy Compliance & Governance Tools
  - 4.6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Healthcare Data Technology Market: Regional Estimates & Trend Analysis

5.1. Regional Market Dashboard
5.2. Regional Market: Key Takeaways
5.3. North America
- 5.3.1. North America Healthcare Data Technology market estimates and forecasts, 2021 - 2033 (USD Million)
- 5.3.2. U.S.
  - 5.3.2.1. Key country dynamic
  - 5.3.2.2. Regulatory framework
  - 5.3.2.3. Competitive insights
  - 5.3.2.4. U.S. Healthcare Data Technology market estimates and forecasts, 2021 - 2033 (USD Million)
- 5.3.3. Canada
  - 5.3.3.1. Key country dynamic
  - 5.3.3.2. Regulatory framework
  - 5.3.3.3. Competitive insights
  - 5.3.3.4. Canada Healthcare Data Technology market estimates and forecasts, 2021 - 2033 (USD Million)
- 5.3.4. Mexico
  - 5.3.4.1. Key country dynamic
  - 5.3.4.2. Regulatory framework
  - 5.3.4.3. Competitive insights
  - 5.3.4.4. Mexico Healthcare Data Technology market estimates and forecasts, 2021 - 2033 (USD Million)
5.4. Europe
- 5.4.1. Europe Healthcare Data Technology market estimates and forecasts, 2021 - 2033 (USD Million)
- 5.4.2. Germany
  - 5.4.2.1. Key country dynamic
  - 5.4.2.2. Regulatory framework
  - 5.4.2.3. Competitive insights
  - 5.4.2.4. Germany Healthcare Data Technology market estimates and forecasts, 2021 - 2033 (USD Million)
- 5.4.3. UK
  - 5.4.3.1. Key country dynamic
  - 5.4.3.2. Regulatory framework
  - 5.4.3.3. Competitive insights
  - 5.4.3.4. UK Healthcare Data Technology market estimates and forecasts, 2021 - 2033 (USD Million)
- 5.4.4. France
  - 5.4.4.1. Key country dynamic
  - 5.4.4.2. Regulatory framework
  - 5.4.4.3. Competitive insights
  - 5.4.4.4. France Healthcare Data Technology market estimates and forecasts, 2021 - 2033 (USD Million)
- 5.4.5. Italy
  - 5.4.5.1. Key country dynamic
  - 5.4.5.2. Regulatory framework
  - 5.4.5.3. Competitive insights
  - 5.4.5.4. Italy Healthcare Data Technology market estimates and forecasts, 2021 - 2033 (USD Million)
- 5.4.6. Spain
  - 5.4.6.1. Key country dynamic
  - 5.4.6.2. Regulatory framework
  - 5.4.6.3. Competitive insights
  - 5.4.6.4. Spain Healthcare Data Technology market estimates and forecasts, 2021 - 2033 (USD Million)
- 5.4.7. Denmark
  - 5.4.7.1. Key country dynamic
  - 5.4.7.2. Regulatory framework
  - 5.4.7.3. Competitive insights
  - 5.4.7.4. Denmark Healthcare Data Technology market estimates and forecasts, 2021 - 2033 (USD Million)
- 5.4.8. Sweden
  - 5.4.8.1. Key country dynamic
  - 5.4.8.2. Regulatory framework
  - 5.4.8.3. Competitive insights
  - 5.4.8.4. Sweden Healthcare Data Technology market estimates and forecasts, 2021 - 2033 (USD Million)
- 5.4.9. Norway
  - 5.4.9.1. Key country dynamic
  - 5.4.9.2. Regulatory framework
  - 5.4.9.3. Competitive insights
  - 5.4.9.4. Norway Healthcare Data Technology market estimates and forecasts, 2021 - 2033 (USD Million)
5.5. Asia Pacific
- 5.5.1. Asia Pacific Healthcare Data Technology market estimates and forecasts, 2021 - 2033 (USD Million)
- 5.5.2. Japan
  - 5.5.2.1. Key country dynamic
  - 5.5.2.2. Regulatory framework
  - 5.5.2.3. Competitive insights
  - 5.5.2.4. Japan Healthcare Data Technology market estimates and forecasts, 2021 - 2033 (USD Million)
- 5.5.3. China
  - 5.5.3.1. Key country dynamic
  - 5.5.3.2. Regulatory framework
  - 5.5.3.3. Competitive insights
  - 5.5.3.4. China Healthcare Data Technology market estimates and forecasts, 2021 - 2033 (USD Million)
- 5.5.4. India
  - 5.5.4.1. Key country dynamic
  - 5.5.4.2. Regulatory framework
  - 5.5.4.3. Competitive insights
  - 5.5.4.4. India Healthcare Data Technology market estimates and forecasts, 2021 - 2033 (USD Million)
- 5.5.5. South Korea
  - 5.5.5.1. Key country dynamic
  - 5.5.5.2. Regulatory framework
  - 5.5.5.3. Competitive insights
  - 5.5.5.4. South Korea Healthcare Data Technology market estimates and forecasts, 2021 - 2033 (USD Million)
- 5.5.6. Australia
  - 5.5.6.1. Key country dynamic
  - 5.5.6.2. Regulatory framework
  - 5.5.6.3. Competitive insights
  - 5.5.6.4. Australia Healthcare Data Technology market estimates and forecasts, 2021 - 2033 (USD Million)
- 5.5.7. Thailand
  - 5.5.7.1. Key country dynamic
  - 5.5.7.2. Regulatory framework
  - 5.5.7.3. Competitive insights
  - 5.5.7.4. Thailand Healthcare Data Technology market estimates and forecasts, 2021 - 2033 (USD Million)
5.6. Latin America
- 5.6.1. Latin America Healthcare Data Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.6.2. Brazil
  - 5.6.2.1. Key country dynamic
  - 5.6.2.2. Regulatory framework
  - 5.6.2.3. Competitive insights
  - 5.6.2.4. Brazil Healthcare Data Technology market estimates and forecasts, 2021 - 2033 (USD Million)
- 5.6.3. Argentina
  - 5.6.3.1. Key country dynamic
  - 5.6.3.2. Regulatory framework
  - 5.6.3.3. Competitive insights
  - 5.6.3.4. Argentina Healthcare Data Technology market estimates and forecasts, 2021 - 2033 (USD Million)
5.7. MEA
- 5.7.1. MEA Healthcare Data Technology market estimates and forecasts, 2021 - 2033 (USD Million)
- 5.7.2. South Africa
  - 5.7.2.1. Key country dynamic
  - 5.7.2.2. Regulatory framework
  - 5.7.2.3. Competitive insights
  - 5.7.2.4. South Africa Healthcare Data Technology market estimates and forecasts, 2021 - 2033 (USD Million)
- 5.7.3. Saudi Arabia
  - 5.7.3.1. Key country dynamic
  - 5.7.3.2. Regulatory framework
  - 5.7.3.3. Competitive insights
  - 5.7.3.4. Saudi Arabia Healthcare Data Technology market estimates and forecasts, 2021 - 2033 (USD Million)
- 5.7.4. UAE
  - 5.7.4.1. Key country dynamic
  - 5.7.4.2. Regulatory framework
  - 5.7.4.3. Competitive insights
  - 5.7.4.4. UAE Healthcare Data Technology market estimates and forecasts, 2021 - 2033 (USD Million)
- 5.7.5. Kuwait
  - 5.7.5.1. Key country dynamic
  - 5.7.5.2. Regulatory framework
  - 5.7.5.3. Competitive insights
  - 5.7.5.4. Kuwait Healthcare Data Technology market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Competitive Landscape

6.1. Participant Overview
6.2. Company Market Position Analysis/ Share Analysis (2024)
6.3. Company Categorization
6.4. Strategy Mapping
6.5. Company Profiles/Listing
- 6.5.1. IQVIA
  - 6.5.1.1. Overview
  - 6.5.1.2. Financial performance
  - 6.5.1.3. Product benchmarking
  - 6.5.1.4. Strategic initiatives
- 6.5.2. Veeva Systems
  - 6.5.2.1. Overview
  - 6.5.2.2. Financial performance
  - 6.5.2.3. Product benchmarking
  - 6.5.2.4. Strategic initiatives
- 6.5.3. Medidata (Dassault Systemes)
  - 6.5.3.1. Overview
  - 6.5.3.2. Financial performance
  - 6.5.3.3. Product benchmarking
  - 6.5.3.4. Strategic initiatives
- 6.5.4. BC Platforms
  - 6.5.4.1. Overview
  - 6.5.4.2. Financial performance
  - 6.5.4.3. Product benchmarking
  - 6.5.4.4. Strategic initiatives
- 6.5.5. Quantexa
  - 6.5.5.1. Overview
  - 6.5.5.2. Financial performance
  - 6.5.5.3. Product benchmarking
  - 6.5.5.4. Strategic initiatives
- 6.5.6. Lifebit Biotech Inc.
  - 6.5.6.1. Overview
  - 6.5.6.2. Financial performance
  - 6.5.6.3. Product benchmarking
  - 6.5.6.4. Strategic initiatives
- 6.5.7. FITFILE
  - 6.5.7.1. Overview
  - 6.5.7.2. Financial performance
  - 6.5.7.3. Product benchmarking
  - 6.5.7.4. Strategic initiatives
- 6.5.8. Umedor Ltd
  - 6.5.8.1. Overview
  - 6.5.8.2. Financial performance
  - 6.5.8.3. Product benchmarking
  - 6.5.8.4. Strategic initiatives
- 6.5.9. Aridhia Digital Research Environment
  - 6.5.9.1. Overview
  - 6.5.9.2. Financial performance
  - 6.5.9.3. Product benchmarking
  - 6.5.9.4. Strategic initiatives
- 6.5.10. OM1
  - 6.5.10.1. Overview
  - 6.5.10.2. Financial performance
  - 6.5.10.3. Product benchmarking
  - 6.5.10.4. Strategic initiatives
- 6.5.11. Syneos Health
  - 6.5.11.1. Overview
  - 6.5.11.2. Financial performance
  - 6.5.11.3. Product benchmarking
  - 6.5.11.4. Strategic initiatives
- 6.5.12. Thermo Fisher Scientific Inc.
  - 6.5.12.1. Overview
  - 6.5.12.2. Financial performance
  - 6.5.12.3. Product benchmarking
  - 6.5.12.4. Strategic initiatives
- 6.5.13. Health Data Technologies GmbH
  - 6.5.13.1. Overview
  - 6.5.13.2. Financial performance
  - 6.5.13.3. Product benchmarking
  - 6.5.13.4. Strategic initiatives
- 6.5.14. TriNetX, LLC
  - 6.5.14.1. Overview
  - 6.5.14.2. Financial performance
  - 6.5.14.3. Product benchmarking
  - 6.5.14.4. Strategic initiatives
- 6.5.15. Flatiron Health
  - 6.5.15.1. Overview
  - 6.5.15.2. Financial performance
  - 6.5.15.3. Product benchmarking
  - 6.5.15.4. Strategic initiatives
- 6.5.16. Arcturis Data Limited
  - 6.5.16.1. Overview
  - 6.5.16.2. Financial performance
  - 6.5.16.3. Product benchmarking
  - 6.5.16.4. Strategic initiatives
- 6.5.17. CRIStal Health Limited t/a Akrivia Health
  - 6.5.17.1. Overview
  - 6.5.17.2. Financial performance
  - 6.5.17.3. Product benchmarking
  - 6.5.17.4. Strategic initiatives
- 6.5.18. Holmusk
  - 6.5.18.1. Overview
  - 6.5.18.2. Financial performance
  - 6.5.18.3. Product benchmarking
  - 6.5.18.4. Strategic initiatives
- 6.5.19. Huma
  - 6.5.19.1. Overview
  - 6.5.19.2. Financial performance
  - 6.5.19.3. Product benchmarking
  - 6.5.19.4. Strategic initiatives
- 6.5.20. ICON, plc
  - 6.5.20.1. Overview
  - 6.5.20.2. Financial performance
  - 6.5.20.3. Product benchmarking
  - 6.5.20.4. Strategic initiatives
- 6.5.21. Privitar (Informatica Inc.)
  - 6.5.21.1. Overview
  - 6.5.21.2. Financial performance
  - 6.5.21.3. Product benchmarking
  - 6.5.21.4. Strategic initiatives
- 6.5.22. Datavant
  - 6.5.22.1. Overview
  - 6.5.22.2. Financial performance
  - 6.5.22.3. Product benchmarking
  - 6.5.22.4. Strategic initiatives
- 6.5.23. CogStack
  - 6.5.23.1. Overview
  - 6.5.23.2. Financial performance
  - 6.5.23.3. Product benchmarking
  - 6.5.23.4. Strategic initiatives
- 6.5.24. Evidentli
  - 6.5.24.1. Overview
  - 6.5.24.2. Financial performance
  - 6.5.24.3. Product benchmarking
  - 6.5.24.4. Strategic initiatives
- 6.5.25. The Hyve
  - 6.5.25.1. Overview
  - 6.5.25.2. Financial performance
  - 6.5.25.3. Product benchmarking
  - 6.5.25.4. Strategic initiatives
- 6.5.26. DataRobot, Inc.
  - 6.5.26.1. Overview
  - 6.5.26.2. Financial performance
  - 6.5.26.3. Product benchmarking
  - 6.5.26.4. Strategic initiatives
- 6.5.27. CLARIFY
  - 6.5.27.1. Overview
  - 6.5.27.2. Financial performance
  - 6.5.27.3. Product benchmarking
  - 6.5.27.4. Strategic initiatives
- 6.5.28. Komodo Health, Inc.
  - 6.5.28.1. Overview
  - 6.5.28.2. Financial performance
  - 6.5.28.3. Product benchmarking
  - 6.5.28.4. Strategic initiatives
- 6.5.29. Evidation Health, Inc.
  - 6.5.29.1. Overview
  - 6.5.29.2. Financial performance
  - 6.5.29.3. Product benchmarking
  - 6.5.29.4. Strategic initiatives
- 6.5.30. Oracle (Cerner Corporation)
  - 6.5.30.1. Overview
  - 6.5.30.2. Financial performance
  - 6.5.30.3. Product benchmarking
  - 6.5.30.4. Strategic initiatives
- 6.5.31. Optum, Inc. (UnitedHealth Group)
  - 6.5.31.1. Overview
  - 6.5.31.2. Financial performance
  - 6.5.31.3. Product benchmarking
  - 6.5.31.4. Strategic initiatives
- 6.5.32. Veradigm LLC (formerly Allscripts Healthcare Solutions, Inc)
  - 6.5.32.1. Overview
  - 6.5.32.2. Financial performance
  - 6.5.32.3. Product benchmarking
  - 6.5.32.4. Strategic initiatives
- 6.5.33. DECENTRIQ
  - 6.5.33.1. Overview
  - 6.5.33.2. Financial performance
  - 6.5.33.3. Product benchmarking
  - 6.5.33.4. Strategic initiatives
- 6.5.34. Shaip
  - 6.5.34.1. Overview
  - 6.5.34.2. Financial performance
  - 6.5.34.3. Product benchmarking
  - 6.5.34.4. Strategic initiatives
- 6.5.35. Satori Cyber Ltd
  - 6.5.35.1. Overview
  - 6.5.35.2. Financial performance
  - 6.5.35.3. Product benchmarking
  - 6.5.35.4. Strategic initiatives
- 6.5.36. LynxCare
  - 6.5.36.1. Overview
  - 6.5.36.2. Financial performance
  - 6.5.36.3. Product benchmarking
  - 6.5.36.4. Strategic initiatives